BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12963609)

  • 1. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
    Wheaton DH; Hoffman DR; Locke KG; Watkins RB; Birch DG
    Arch Ophthalmol; 2003 Sep; 121(9):1269-78. PubMed ID: 12963609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
    Hughbanks-Wheaton DK; Birch DG; Fish GE; Spencer R; Pearson NS; Takacs A; Hoffman DR
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4958-66. PubMed ID: 25015354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.
    Hoffman DR; Hughbanks-Wheaton DK; Pearson NS; Fish GE; Spencer R; Takacs A; Klein M; Locke KG; Birch DG
    JAMA Ophthalmol; 2014 Jul; 132(7):866-73. PubMed ID: 24805262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa.
    Hoffman DR; Birch DG
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1009-18. PubMed ID: 7730010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients.
    Daak AA; Ghebremeskel K; Mariniello K; Attallah B; Clough P; Elbashir MI
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):305-11. PubMed ID: 24095588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
    Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
    Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.
    Hoffman DR; Hughbanks-Wheaton DK; Spencer R; Fish GE; Pearson NS; Wang YZ; Klein M; Takacs A; Locke KG; Birch DG
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6646-53. PubMed ID: 26469750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa.
    Gong J; Rosner B; Rees DG; Berson EL; Weigel-DiFranco CA; Schaefer EJ
    Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2596-602. PubMed ID: 1386350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid profiles, antioxidant status, and growth of preterm infants fed diets without or with long-chain polyunsaturated fatty acids. A randomized clinical trial.
    Koletzko B; Sauerwald U; Keicher U; Saule H; Wawatschek S; Böhles H; Bervoets K; Fleith M; Crozier-Willi G
    Eur J Nutr; 2003 Oct; 42(5):243-53. PubMed ID: 14569405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.
    Nobili V; Bedogni G; Alisi A; Pietrobattista A; Risé P; Galli C; Agostoni C
    Arch Dis Child; 2011 Apr; 96(4):350-3. PubMed ID: 21233083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
    Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
    Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.
    Kusumoto A; Ishikura Y; Kawashima H; Kiso Y; Takai S; Miyazaki M
    Br J Nutr; 2007 Sep; 98(3):626-35. PubMed ID: 17445350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipid abnormalities in retinitis pigmentosa and related conditions.
    Converse CA; Hammer HM; Packard CJ; Shepherd J
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 5)():508-12. PubMed ID: 6591588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.